GLG Life Tech Corporation Announces the Appointment of Two New Directors
06 8월 2010 - 12:18AM
Marketwired
GLG Life Tech Corporation (TSX: GLG)(NASDAQ: GLGL) ("GLG" or the
"Company"), the vertically-integrated leader in the agricultural
and commercial development of high quality stevia, announces today
the appointments of David M. Hall and Dr. Hong Zhao Guang to its
Board of Directors.
Mr. Hall is currently a consultant to the life sciences
industry. He is a past business founder, Chief Financial Officer
and Chief Compliance Officer of Angiotech Pharmaceuticals, and an
active advocate for the British Columbia life sciences industry.
During Mr. Hall's tenure with Angiotech, he was involved in $1.2
billion in financing, 11 acquisitions and established one of
Canada's first dedicated Sarbanes Oxley compliance programs. Mr.
Hall is the Past Chair and a current board member of Life Sciences
BC and leads the organization's public policy initiatives. He is
the author of Life Sciences BC's position papers for the Premier's
Competition Council Report and Conversation on Health.
Mr. Hall was also a member of the BC Task Force on PharmaCare
and serves on the board of directors of the International Finance
Centre for British Columbia. Mr. Hall holds an Honours degree in
Economics and an Honours degree in Finance from the University of
Manitoba.
Dr. Hong Zhao Guang is an active leader in both the academic and
business communities in China. Receiving his degree from Shanghai
First Medical College, he has been the vice president of Beijing
Anzhen Hospital and the vice director of the Cardiovascular Disease
Expert Consulting Committee for the Ministry of Public Health in
China. Currently Dr. Hong is directing commissioner with the Aged
Chinese Healthcare Association and the vice group leader for
physicians at Capital Medical Science University, one of the top
ranking academic medical institution in China.
Dr. Hong has written and edited more than ten books and
published more than one hundred academic theses and five hundred
articles for the scientific community. During the last 15 years,
Dr. Hong has devoted his time to the education of citizens
throughout China on the importance of wellness, health and an
active lifestyle, including the prevention of diabetes and
cardiovascular diseases. His books have been read by more than 70
million people and his lectures heard by over 200 million people in
China.
GLG Chairman and CEO Dr. Luke Zhang stated, "We are pleased to
announce the appointments of David Hall and Dr. Hong Zhao Guang to
our Board of Directors. GLG continues to build a global leadership
team whose expertise and strength enable us to strategically
develop and lead the stevia industry in key markets around the
world. Mr. Hall's experience in finance and corporate governance as
well as work in biotechnology will be an important asset for GLG.
Additionally, Dr. Hong is a highly regarded, national leader in
China and an important advocate for health education. Both of these
individuals will bring to GLG experience and guidance as we
continue to grow and deliver our customers a natural, healthy,
sweetening solution for the future."
Both appointments are subject to approval by the TSX.
About GLG Life Tech Corporation
GLG Life Tech Corporation is a global leader in the supply of
high purity stevia extracts, an all natural, zero-calorie sweetener
used in food and beverages. The Company's vertically integrated
operations cover each step in the stevia supply chain including
non-GMO stevia seed breeding, natural propagation, stevia leaf
growth and harvest, proprietary extraction and refining, marketing
and distribution of finished product. GLG's advanced technology,
extraction technique and premier, high quality product offerings
make it a leading producer of high purity, great tasting stevia
extracts. For further information, please visit
www.glglifetech.com.
Forward-looking statements: This press release contains certain
information that may constitute "forward-looking information" and
"forward-looking statements" within the meaning of applicable
Canadian and United States securities laws. All statements relating
to plans, strategies, projections of results of specific activities
or investments, and other statements that are not descriptions of
historical facts may be forward-looking statements. Forward-looking
statements and information are inherently subject to risks and
uncertainties, and actual results could differ materially from
those currently anticipated due to a number of factors, which
include, but are not limited to, operational risks, the effects of
general economic conditions, changing foreign exchange rates and
actions by government authorities, uncertainties associated with
legal proceedings and negotiations, industry supply levels,
competitive pricing pressures and other risks and uncertainties
disclosed in the public documents filed by the Company with
Canadian and United States securities regulatory authorities.
Forward-looking statements and information may be identified by
terms such as "may", "will", "should", "continue", "expect",
"anticipate", "estimate", "believe", "intend", "plan" or "project",
or similar terms or the negatives of these terms. Although we
believe that the expectations reflected in the forward-looking
statements and information are reasonable, we cannot guarantee
future results, levels of activity, performance, or achievements.
The Company's forward-looking statements and information reflect
the beliefs, opinions and projections on the date the statements
are made. The Company assumes no obligation to update
forward-looking information should circumstances or management's
estimates or opinions change, except as required by law.
Contacts: GLG Life Tech Corporation Brian Meadows Chief
Financial Officer +1 (604) 844-2840 info@glglifetech.com
www.glglifetech.com
GLG Life Tech (TSX:GLG)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
GLG Life Tech (TSX:GLG)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024